Who owns XERIS PHARMACEUTICALS INC?
- Ticker: XERS
- CUSIP Number: 98422e103
Tip: Access positions for across all investors
Analyze quarterly positions in Xeris Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xeris Pharmaceuticals stock
Who bought or sold XERIS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 10M | $22M | 6% | Mar 2024 |
|
| Vanguard Group | 7.6M | $17M | 7% | Mar 2024 |
|
| MPM Oncology Impact Management | 4.2M | $9.2M | 4% | Mar 2024 |
|
| Geode Capital Management | 3.0M | $6.7M | 10% | Mar 2024 |
|
| Rosalind Advisors | 2.8M | $6.2M | -20% | Mar 2024 |
|
| Millennium Management | 1.7M | $3.7M | 10% | Mar 2024 |
|
| Nuveen Asset Management | 1.6M | $3.5M | 123% | Mar 2024 |
|
| CenterBook Partners | 1.5M | $3.4M | 100% | Mar 2024 |
|
| Morgan Stanley | 1.3M | $2.9M | 102% | Mar 2024 |
|
| Northern Trust | 1.2M | $2.6M | 1% | Mar 2024 |
|
| AQR Capital Management | 1.1M | $2.5M | 318% | Mar 2024 |
|
| Redmile Group | 1.0M | $2.3M | 0% | Mar 2024 |
|
| Ameriprise Financial | 953k | $2.1M | 62% | Mar 2024 |
|
| D. E. Shaw & Co | 707k | $1.6M | -33% | Mar 2024 |
|
| Bank of America Corporation | 628k | $1.4M | 141% | Mar 2024 |
|
| Invenomic Capital Management | 605k | $1.3M | 6% | Mar 2024 |
|
| Tudor Investment Corporation | 573k | $1.3M | 4% | Mar 2024 |
|
| NEA Management Company | 419k | $926k | 100% | Mar 2024 |
|
| Lazard Asset Management | 404k | $948k | 28% | Dec 2023 |
|
| Jpmorgan Chase & Co | 374k | $827k | 16% | Mar 2024 |
|
| Charles Schwab Investment Management | 366k | $810k | 1% | Mar 2024 |
|
| Bank of New York Mellon | 349k | $770k | -6% | Mar 2024 |
|
| Rubric Capital Management | 311k | $687k | 100% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 291k | $642k | 100% | Mar 2024 |
|
| Alpine Partners VI | 270k | $635k | -10% | Dec 2023 |
|
| XTX Topco | 255k | $564k | 100% | Mar 2024 |
|
| Goldman Sachs Group | 251k | $556k | -3% | Mar 2024 |
|
| Citadel Advisors | 241k | $534k | -65% | Mar 2024 |
|
| Jane Street | 230k | $508k | 3% | Mar 2024 |
|
| Barclays | 205k | $453k | -26% | Mar 2024 |
|
| Man Group | 199k | $440k | 100% | Mar 2024 |
|
| UBS Group | 197k | $435k | 46% | Mar 2024 |
|
| Brown Advisory Holdings Incorporated | 190k | $421k | -10% | Mar 2024 |
|
| Thompson, Siegel, & Walmsley | 190k | $420k | 100% | Mar 2024 |
|
| Commonwealth Equity Services | 187k | $413k | 0% | Mar 2024 |
|
| Hrt Financial | 182k | $402k | 109% | Mar 2024 |
|
| Qube Research & Technologies | 179k | $395k | 231% | Mar 2024 |
|
| Rhumbline Advisers | 178k | $393k | 4% | Mar 2024 |
|
| Diversified Trust Company | 176k | $388k | 13% | Mar 2024 |
|
| Two Sigma Investments | 130k | $287k | 33% | Mar 2024 |
|
| T. Rowe Price Associates | 126k | $278k | 9% | Mar 2024 |
|
| Parkman Healthcare Partners | 101k | $223k | 100% | Mar 2024 |
|
| Mariner Wealth Advisors | 98k | $217k | -24% | Mar 2024 |
|
| Principal Financial Group | 90k | $198k | 100% | Mar 2024 |
|
| Graham Capital Management | 87k | $191k | 135% | Mar 2024 |
|
| OrbiMed Advisors | 80k | $178k | 100% | Mar 2024 |
|
| Alliancebernstein | 80k | $189k | 0% | Dec 2023 |
|
| Sigma Planning | 77k | $169k | 100% | Mar 2024 |
|
| Deerfield Management Company | 74k | $163k | 100% | Mar 2024 |
|
| MetLife Investment Advisors | 71k | $167k | 0% | Dec 2023 |
|
| Dynamic Technology Lab Private | 69k | $153k | 100% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 69k | $152k | 4% | Mar 2024 |
|
| American International | 66k | $155k | 0% | Dec 2023 |
|
| Soleus Capital Management | 62k | $137k | 0% | Mar 2024 |
|
| GPS Wealth Strategies Group | 62k | $137k | 0% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 61k | $133k | -6% | Mar 2024 |
|
| Annandale Capital | 56k | $131k | 123% | Dec 2023 |
|
| Dimensional Fund Advisors | 55k | $122k | 100% | Mar 2024 |
|
| Ieq Capital | 54k | $120k | 8% | Mar 2024 |
|
| Stoneridge Investment Partners | 53k | $118k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 52k | $116k | 17% | Mar 2024 |
|
| Deltec Asset Management | 52k | $115k | -80% | Mar 2024 |
|
| LJI Wealth Management | 52k | $114k | -16% | Mar 2024 |
|
| Chevy Chase Trust Holdings | 51k | $113k | 0% | Mar 2024 |
|
| Weiss Asset Management LP[1 | 50k | $111k | 100% | Mar 2024 |
|
| Susquehanna International | 49k | $109k | -83% | Mar 2024 |
|
| Ing Investment Management | 44k | $98k | -18% | Mar 2024 |
|
| Boothbay Fund Management | 43k | $96k | 100% | Mar 2024 |
|
| Citigroup | 42k | $92k | 90% | Mar 2024 |
|
| LPL Financial | 39k | $86k | 100% | Mar 2024 |
|
| Mackenzie Financial | 35k | $78k | 36% | Mar 2024 |
|
| Yakira Capital Management | 35k | $76k | 100% | Mar 2024 |
|
| Cambridge Investment Research Advisors | 34k | $75k | 6% | Mar 2024 |
|
| Centiva Capital | 34k | $74k | -21% | Mar 2024 |
|
| ProShare Advisors | 34k | $74k | 28% | Mar 2024 |
|
| Quarry | 30k | $65k | 48% | Mar 2024 |
|
| Creative Planning | 29k | $65k | 100% | Mar 2024 |
|
| ProFund Advisors | 28k | $63k | 100% | Mar 2024 |
|
| China Universal Asset Management | 27k | $59k | 66% | Mar 2024 |
|
| Advisor Group Holdings | 26k | $57k | 39% | Mar 2024 |
|
| Goldstein Advisors | 25k | $56k | 0% | Mar 2024 |
|
| New York State Common Retirement Fund | 23k | $50k | 0% | Mar 2024 |
|
| Rafferty Asset Management | 21k | $47k | 100% | Mar 2024 |
|
| SG Americas Securities | 21k | $46k | -38% | Mar 2024 |
|
| Apollon Wealth Management | 20k | $45k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 19k | $42k | -66% | Mar 2024 |
|
| CSS | 18k | $40k | 100% | Mar 2024 |
|
| Pathstone Holdings | 18k | $40k | 100% | Mar 2024 |
|
| Van Hulzen Asset Management | 18k | $40k | 0% | Mar 2024 |
|
| Victory Capital Management | 17k | $38k | -1% | Mar 2024 |
|
| Bayesian Capital Management | 17k | $37k | 100% | Mar 2024 |
|
| Crystalline Management | 17k | $37k | 100% | Mar 2024 |
|
| Legal & General Group | 15k | $32k | 0% | Mar 2024 |
|
| Avenue 1 Advisors | 14k | $31k | 13% | Mar 2024 |
|
| Empirical Financial Services, LLC d/b/a Empirical Wealth Management | 14k | $30k | 0% | Mar 2024 |
|
| California State Teachers Retirement System | 13k | $30k | -54% | Mar 2024 |
|
| CWM | 13k | $29k | 69284% | Mar 2024 |
|
| FMR | 13k | $29k | 41% | Mar 2024 |
|
| GSA Capital Partners | 12k | $26k | -97% | Mar 2024 |
|
| CI Private Wealth | 11k | $24k | 100% | Mar 2024 |
|
| Hsbc Holdings | 11k | $25k | 0% | Dec 2023 |
|
| Janney Montgomery Scott | 10k | $23k | 100% | Mar 2024 |
|
| Two Sigma Advisers | 10k | $22k | 100% | Mar 2024 |
|
| Summit Investment Advisors | 9.9k | $22k | 0% | Mar 2024 |
|
| Atlantic Trust | 5.7k | $12k | 100% | Mar 2024 |
|
| ADAR1 Capital Management | 5.1k | $11k | 100% | Mar 2024 |
|
| Amalgamated Bank | 4.6k | $10k | -76% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 4.1k | $9.6k | 100% | Dec 2023 |
|
| Parallel Advisors | 3.3k | $7.3k | 0% | Mar 2024 |
|
| Benjamin F. Edwards & Company | 3.0k | $7.0k | 0% | Mar 2024 |
|
| National Bank Of Canada /fi/ | 2.4k | $5.4k | 0% | Dec 2023 |
|
| Fortitude Family Office | 2.3k | $5.1k | 0% | Mar 2024 |
|
| Tower Research Capital | 2.2k | $4.8k | -88% | Mar 2024 |
|
| Hanson McClain Advisors | 2.1k | $4.6k | 10% | Mar 2024 |
|
| Creative Financial Designs | 2.1k | $4.5k | 0% | Mar 2024 |
|
| BFSG | 2.0k | $4.4k | 0% | Mar 2024 |
|
| TSFG | 708.00 | $2.0k | 100% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 570.00 | $1.3k | 100% | Mar 2024 |
|
| EverSource Wealth Advisors | 468.00 | $1.1k | 0% | Mar 2024 |
|
| Brian McDonald | 417.00 | $921.987000 | 100% | Mar 2024 |
|
| Global Retirement Partners | 413.00 | $913.019100 | 0% | Mar 2024 |
|
| Daiwa Securities Group | 404.00 | $999.980800 | 0% | Mar 2024 |
|
| Allspring Global Investments Holdings | 353.00 | $779.988800 | 111% | Mar 2024 |
|
| Russell Investments | 202.00 | $445.995800 | 100% | Mar 2024 |
|
| IFP Advisors | 200.00 | $470.000000 | 0% | Dec 2023 |
|
| SOA Wealth Advisors | 118.00 | $261.004200 | 0% | Mar 2024 |
|
| Farther Finance Advisors | 103.00 | $219.997700 | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 27.00 | $59.000400 | 100% | Mar 2024 |
|
Who sold out of Xeris Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| ExodusPoint Capital Management | Sep 2023 | 185k | $345k |
| Tang Capital Management | Dec 2023 | 150k | $353k |
| PanAgora Asset Management | Dec 2023 | 140k | $330k |
| Group One Trading | Sep 2023 | 66k | $123k |
| Caption Management | Dec 2023 | 44k | $104k |
| Florida State Board of Administration | Dec 2023 | 38k | $89k |
| Walleye Trading Advisors | Dec 2023 | 36k | $84k |
| Verition Fund Management | Sep 2023 | 25k | $46k |
| Damian Sousa | Dec 2023 | 20k | $48k |
| Two Sigma Securities | Dec 2023 | 17k | $40k |
| Bridgeway Capital Management | Sep 2023 | 14k | $26k |
| Whitener Capital Management | Dec 2023 | 12k | $28k |
| Sawtooth Asset Management | Sep 2023 | 11k | $21k |
| Aigen Investment Management | Sep 2023 | 10k | $19k |
| O'Dell Group | Dec 2023 | 3.3k | $7.8k |
| Cutler | Dec 2023 | 700.00 | $1.0k |
| Pnc Financial Services | Dec 2023 | 30.00 | $71.001000 |